Johnson & Johnson (NYSE: JNJ) announced today that 43 presentations showcasing the Company's rheumatology pipeline and portfolio will be featured at the American College of Rheumatology (ACR) 2024 ...
This study seeks to show that it’s possible to reverse both Rheumatoid Arthritis (RA) and Psoriasis by integrating ... Project IMPACT: Discovering the best way to manage autoimmune conditions Project ...
Some 40 knee arthritis sufferers have undergone the treatment, called genicular arterial embolisation ... While it doesn't work for everyone, it offers a hopeful and exciting new option.' 'The ...
Testing new substances in animals is a regulatory cornerstone of drug development. At the same time, the development of animal free testing methods is progressing. In this context the pharmaceutical ...